Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 678,393 | 126,266 | 89,258 | 673,658 | 173,782 |
| Marketable Securities | 8,144 | 407,491 | 532,144 | 62,060 | 79,397 |
| Receivables | 41,883 | 28,455 | 63,684 | 8,452 | 10,448 |
| Inventories | 16,530 | 6,887 | 0 | N/A | N/A |
| TOTAL | $755,110 | $702,490 | $690,015 | $748,970 | $266,516 |
| Non-Current Assets | |||||
| PPE Net | 33,647 | 42,743 | 127,198 | 129,476 | 123,657 |
| Investments And Advances | 2,972 | 61,118 | 55,820 | 10,506 | 71,010 |
| Other Non-Current Assets | 35,111 | 51,046 | 7,565 | 9,698 | 8,369 |
| TOTAL | $71,730 | $154,907 | $190,583 | $149,680 | $203,036 |
| Total Assets | $826,840 | $857,397 | $880,598 | $898,650 | $469,552 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,789 | 6,088 | 9,139 | 5,509 | 6,223 |
| Accrued Expenses | 118,333 | 83,816 | 66,123 | 63,781 | 50,914 |
| TOTAL | $163,187 | $102,745 | $89,033 | $85,960 | $65,125 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,547 | 490 | 13,771 | 16,670 | 7,988 |
| Other Non-Current Liabilities | 58,339 | 82,187 | 123,948 | 25,291 | 21,045 |
| TOTAL | $222,204 | $219,246 | $263,095 | $264,952 | $229,318 |
| Total Liabilities | $385,391 | $321,991 | $352,128 | $350,912 | $294,443 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,662 | 3,520 | 3,422 | 3,307 | 2,556 |
| Common Shares | 914 | 877 | 854 | 825 | 637 |
| Retained earnings | -974,011 | -784,720 | -715,827 | -630,657 | -469,742 |
| Other shareholders' equity | 14,772 | 18,524 | 16,990 | 17,476 | 18,311 |
| TOTAL | $441,449 | $535,406 | $528,470 | $547,738 | $175,109 |
| Total Liabilities And Equity | $826,840 | $857,397 | $880,598 | $898,650 | $469,552 |